BCM
ADTN icon

Bayesian Capital Management’s Adtran ADTN Stock Holding History

Bayesian Capital Management’s Portfolio ADTN Stock Details ADTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,000
Closed -$256K – 694
2024
Q1 		$256K Buy
+47,000
New +$300K 0.02% 604

Other funds holding ADTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's ADTN Position: Q2 2024 in Review

Bayesian Capital Management sold out of Adtran (ADTN) in Q2 2024, closing a stake of 47,000 shares — an estimated $256K sold.

Bayesian Capital Management first reported a position in ADTN in Q1 2024 and held it in 1 quarter. The position peaked at $256K in Q1 2024. 157 funds tracked by Wall St. Rank hold ADTN as of Q2 2024.

  • Bayesian Capital Management reported no remaining Adtran position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 47,000 Adtran shares in Q2 2024, an estimated $256K.
  • Bayesian Capital Management first reported a position in Adtran in Q1 2024 and held it in 1 quarter.
  • Bayesian Capital Management's Adtran position peaked at $256K in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Adtran as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.